The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer, according to NPR.
Curated by
Updated 11 months ago
Save
Browse more
Continue from source
Browse more from MIT Technology Review
Contribute to FoundryBase
Sign in to suggest resources and start building your own collection.